Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


07.01.2019

3 Am J Surg
1 BMC Cancer
1 Breast Cancer
1 Breast Cancer Res
9 Breast Cancer Res Treat
2 Breast J
1 Cancer Lett
1 Carcinogenesis
1 Cell
1 Clin Cancer Res
1 Eur J Surg Oncol
2 Int J Cancer
1 J Biol Chem
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. KUPSTAS A, Ibrar W, Hayward RD, Ockner D, et al
    A novel modality for intraoperative margin assessment and its impact on re-excision rates in breast conserving surgery.
    Am J Surg. 2018;215:400-403.
    PubMed     Text format     Abstract available

  2. CANDELARIA RP, Hansakul P, Thompson AM, Le-Petross H, et al
    Analysis of stereotactic biopsies performed on suspicious calcifications identified within 24 months after completion of breast conserving surgery and radiation therapy for early breast cancer: Can biopsy be obviated?
    Am J Surg. 2018;215:693-698.
    PubMed     Text format     Abstract available

  3. KOZICK Z, Hashmi A, Dove J, Hunsinger M, et al
    Disparities in compliance with the Oncotype DX breast cancer test in the United States: A National Cancer Data Base assessment.
    Am J Surg. 2018;215:686-692.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. HAMDI Y, Ben Rekaya M, Jingxuan S, Nagara M, et al
    A genome wide SNP genotyping study in the Tunisian population: specific reporting on a subset of common breast cancer risk loci.
    BMC Cancer. 2018;18:1295.
    PubMed     Text format     Abstract available


    Breast Cancer

  5. SHARMA R
    Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990-2016: evidence from Global Burden of Disease Study 2016.
    Breast Cancer. 2019 Jan 2. pii: 10.1007/s12282-018-00941.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  6. HUDSON S, Vik Hjerkind K, Vinnicombe S, Allen S, et al
    Adjusting for BMI in analyses of volumetric mammographic density and breast cancer risk.
    Breast Cancer Res. 2018;20:156.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  7. KIM SJ, Zhang CXW, Demsky R, Armel S, et al
    Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case-control study.
    Breast Cancer Res Treat. 2019 Jan 2. pii: 10.1007/s10549-018-05118.
    PubMed     Text format     Abstract available

  8. KENSLER KH, Eliassen AH, Rosner BA, Hankinson SE, et al
    Pre-diagnostic sex hormone levels and survival among breast cancer patients.
    Breast Cancer Res Treat. 2019 Jan 2. pii: 10.1007/s10549-018-05121.
    PubMed     Text format     Abstract available

  9. PATEL DA, Xi J, Luo J, Hassan B, et al
    Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
    Breast Cancer Res Treat. 2019 Jan 2. pii: 10.1007/s10549-018-05106.
    PubMed     Text format     Abstract available

  10. HU J, Wang X, Guo S, Chen F, et al
    Peer support interventions for breast cancer patients: a systematic review.
    Breast Cancer Res Treat. 2019 Jan 2. pii: 10.1007/s10549-018-5033.
    PubMed     Text format     Abstract available

  11. LYES MA, Payne S, Ferrell P, Pizzo SV, et al
    Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence.
    Breast Cancer Res Treat. 2018 Dec 29. pii: 10.1007/s10549-018-05103.
    PubMed     Text format     Abstract available

  12. O'BRIEN P, Matheson K, Jeyakumar A, Anderson K, et al
    The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis.
    Breast Cancer Res Treat. 2019 Jan 2. pii: 10.1007/s10549-018-05114.
    PubMed     Text format     Abstract available

  13. GOGATE A, Rotter JS, Trogdon JG, Meng K, et al
    An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer.
    Breast Cancer Res Treat. 2019 Jan 2. pii: 10.1007/s10549-018-05099.
    PubMed     Text format     Abstract available

  14. WUNDERLE M, Pretscher J, Brucker SY, Volz B, et al
    Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
    Breast Cancer Res Treat. 2019 Jan 2. pii: 10.1007/s10549-018-05115.
    PubMed     Text format     Abstract available

  15. CARUANA E, Foucher Y, Tessier P, Frenel JS, et al
    Patient-centered simulations to assess the usefulness of the 70-gene signature for adjuvant chemotherapy administration in early-stage breast cancer.
    Breast Cancer Res Treat. 2019 Jan 2. pii: 10.1007/s10549-018-05107.
    PubMed     Text format     Abstract available


    Breast J

  16. CAVIGGIOLI F, Klinger F, Lisa A, Rimondo A, et al
    The post-mastectomy pain syndrome-A systematic review of the treatment modalities.
    Breast J. 2018;24:451-452.
    PubMed     Text format    

  17. JEON W, Jang BS, Jeon SH, Kim JH, et al
    Analysis of survival outcomes based on molecular subtypes in breast cancer brain metastases: A single institutional cohort.
    Breast J. 2018;24:920-926.
    PubMed     Text format     Abstract available


    Cancer Lett

  18. TU M, Lu C, Lv N, Wei J, et al
    Corrigendum to 'Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2' [Cancer Lett. 2016 Dec 28; 383 (2):272-281].
    Cancer Lett. 2018 Dec 26. pii: S0304-3835(18)30717.
    PubMed     Text format    


    Carcinogenesis

  19. HARQUAIL J, LeBlanc N, Ouellette RJ, Robichaud GA, et al
    MiRNAs 484 and 210 Regulate Pax-5 Expression and Function in Breast Cancer Cells.
    Carcinogenesis. 2019 Jan 3. pii: 5272434. doi: 10.1093.
    PubMed     Text format     Abstract available


    Cell

  20. CASASENT AK, Schalck A, Gao R, Sei E, et al
    Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.
    Cell. 2018;172.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  21. HURVITZ SA, O'Shaughnessy J, Mason G, Yardley D, et al
    Central Nervous System Metastasis in Patients With HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival From SystHERs.
    Clin Cancer Res. 2018 Dec 28. pii: 1078-0432.CCR-18-2366.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  22. QIAO W, Liu H, Guo W, Li P, et al
    Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2018 Dec 25. pii: S0748-7983(18)32041.
    PubMed     Text format     Abstract available


    Int J Cancer

  23. OH H, Pfeiffer RM, Falk RT, Horne HN, et al
    Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
    Int J Cancer. 2018;143:496-507.
    PubMed     Text format     Abstract available

  24. KWOK ZH, Roche V, Chew XH, Fadieieva A, et al
    A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers.
    Int J Cancer. 2018;143:668-678.
    PubMed     Text format     Abstract available


    J Biol Chem

  25. AGGARWAL S, Gabrovsek L, Langeberg LK, Golkowski M, et al
    Depletion of dAKAP1-protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility.
    J Biol Chem. 2018 Dec 31. pii: RA118.006741. doi: 10.1074/jbc.RA118.006741.
    PubMed     Text format     Abstract available


    PLoS One

  26. SCHUETZ JM, Grundy A, Lee DG, Lai AS, et al
    Genetic variants in genes related to inflammation, apoptosis and autophagy in breast cancer risk.
    PLoS One. 2019;14:e0209010.
    PubMed     Text format     Abstract available

  27. HAHN EC, Bittar CM, Vianna FSL, Netto CBO, et al
    TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients.
    PLoS One. 2018;13:e0209934.
    PubMed     Text format     Abstract available

  28. BERTAUT A, Coudert J, Bengrine L, Dancourt V, et al
    Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    PLoS One. 2018;13:e0198939.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: